...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith funding???
5
Jun 15, 2019 01:28PM
4
Jun 15, 2019 07:08PM
4
Jun 15, 2019 09:33PM
4
Jun 16, 2019 07:41AM
3
Jun 16, 2019 12:37PM
3
Jun 17, 2019 01:57PM
3
Jun 17, 2019 04:53PM
2
Jun 17, 2019 05:00PM
2
Jun 18, 2019 12:19PM
2
Jun 24, 2019 01:48PM
3
Jun 24, 2019 04:43PM
6
Jun 25, 2019 12:44AM
4
Jun 25, 2019 10:59AM
7
Jun 25, 2019 11:45AM
4
Jun 25, 2019 12:45PM
4
Jun 25, 2019 01:13PM
4
Jun 25, 2019 01:17PM

fouremm....Yes, it shows up on RVX financials as a receivable.

RVXOT,  I was not questioning your numbers. I'm sure they are correct. Although Zenith may be operating on fumes, Resverlogix helps to maintain their existence so to speak. 

 

Koo

5
Jun 25, 2019 02:54PM
4
Jun 25, 2019 03:01PM
3
Jun 26, 2019 12:16PM

Jun 26, 2019 01:02PM
3
Jun 26, 2019 02:30PM
Share
New Message
Please login to post a reply